Dova Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
28 Maggio 2019 - 10:30PM
Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Dr.
David Zaccardelli, President and Chief Executive Officer, will
present a company overview at the Jefferies 2019 Global Healthcare
Conference on Tuesday, June 4, 2019 at 11:00 a.m. ET in New York,
NY.
A live audio webcast of the event will be
available via the "Investor Relations" page of the Dova website,
www.dova.com. Please log on through Dova's website approximately 10
minutes before the scheduled start time. A replay of the webcast
will be archived on Dova's website for 90 days following the
call.
About Dova Pharmaceuticals,
Inc.
Dova is a pharmaceutical company focused on acquiring,
developing, and commercializing drug candidates for rare diseases
where there is a high unmet need, with an initial focus on
addressing thrombocytopenia. Dova’s proprietary pipeline includes
one commercial product, DOPTELET®, for the treatment of
thrombocytopenia in adult patients with chronic liver disease
scheduled to undergo a procedure.
Contacts
Mark W. Hahn (919) 338-7936 mhahn@dova.com
Westwicke John Woolford (443) 213-0506
john.woolford@westwicke.com
Grafico Azioni Dova Pharmaceuticals (NASDAQ:DOVA)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Dova Pharmaceuticals (NASDAQ:DOVA)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Dova Pharmaceuticals Inc (NASDAQ): 0 articoli recenti
Più Articoli Notizie